Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 2 The evolution of functional scores (at admission and at one month after therapy); for the two groups

From: Guillain–Barre syndrome: small-volume plasmapheresis versus intravenous immunoglobulin—3rd level hospital experience

 

SVP group

IVIg group

P value

Difference MRC UL 1 month-initial

1.0 ± 1.1

1.3 ± 1.3

0.40

Difference MRC LL 1 month-initial

1.3 ± 1.2

1.4 ± 1.0

0.55

Difference MRC sum 1 month-initial

15.6 ± 14.3

14.7 ± 13.6

0.65

Difference Hughes initial-1 month

1.5 ± 1.3

1.7 ± 1.2

0.58

  1. SVP small-volume plasmapheresis
  2. IVIg intravenous immunoglobulin
  3. MRC Medical Research Council
  4. UL upper limbs
  5. LL lower limbs
Back to article page